Medical Director, UNC Lineberger Comprehensive Cancer Center (Chapel Hill, NC)

Bachelor of Science, University of California, Irvine

Dr. Bert H. O'Neil has 23 years of experience in the fields of Medical Oncology and Hematology. He earned his BS in Biological Sciences from the University of California, Irvine and his MD from David Geffen School of Medicine at UCLA. After completing his residency in Medicine, he went on to complete his fellowship in Hematology and Oncology at the UCSF School of Medicine. Today, this expert is board-certified in Medical Oncology. Formerly, this expert served as the Joseph W. and Jackie J. Cusick Professor of Oncology at the Indiana University School of Medicine, as the Chief Scientific Officer of Hoosier Cancer Research Network, and as the Executive Medical Director of Early Phase Oncology at Eli Lilly and Company. He is currently the Medical Director of Oncology Research for Community Health Network.

b********@e*****.com

(317) ***-****

Indianapolis, Indiana

Comprehensive data on expert witnesses: Access detailed litigation history and performance metrics.

Swift assessment: Quickly evaluate an expert's track record.

Informed decisions: Make better choices when selecting or challenging expert witnesses in any case.

LIVE DEMO

Get a FREE Demo of Dr. Bert O'Neil, MD's Radar Profile

Radar Metrics At A Glance

Expert Witness Activity

lock icon

Plaintiff Cases

lock icon

Defense Cases

lock icon

Expert Challenges

lock icon

Deposition Transcripts

lock icon

Publications

173

Media & News

208

Social Media Mentions

15

Expert Institute operates independently and objectively as an expert witness data provider. Expert Institute does not employ, endorse, or have an affiliation with any expert witnesses for which data is provided.

Expert Witness Activity

Case Name

Role

Filed Date

Unlock Dr. Bert O'Neil, MD's full profile

Litigation Analytics

Retained By

Defense

Plaintiff

33%67%

Activity over time

0

25

50

75

100

2000

0

2002

0

2004

0

2006

0

2008

0

2010

0

Activity by state

Map of USA

Case Outcome

0

25

50

75

100

Publications

Radar found 173 records

Title

Type

First-in-human study of AMG 193, an MTA-cooperative PRMT5 inhibitor, in patients with MTAP-deleted solid tumors: results from phase I dose exploration

Journal Article

Common variation in a long non-coding RNA gene modulates variation of circulating TGF-β2 levels in metastatic colorectal cancer patients (Alliance)

Journal Article

A phase II trial of UGT1A1 genotype-guided FOLFIRI plus bevacizumab as first-line therapy for advanced, unresectable colorectal cancer

Journal Article

Radar monitors a wide array of publication sources, including links to abstracts.

Review book chapters, journal articles, research papers, trade publications, technical reports, conference proceedings, and more.

image

Media & News

Radar found 208 records

Title

Description

Cancer Clinics of Excellence (CCE) Announces ...

Jun 12, 2024 ----- In addition, Linda Bosserman, MD ,Wilshire Oncology Medical Group was named Chief Medical Officer. ... Bert O'Neil , MD , University of North ...

A Clinical Trial of Pembrolizumab (MK-3475) Evaluating ...

May 15, 2024 ----- ... Tumors ( KEYNOTE 158). B. Bert O'Neil , MD . Primary Investigator. J. Jessica MacLean. Primary Investigator. Not Recruiting. 18-100 years. All.

Association of Diet Quality with Survival among People ...

by EL Van Blarigan 2020 Cited by 10 ----- ... O'Neil , Bert H.; Shaw, James E.; Polite, Blase N.; Hochster, Howard S.; Atkins, James N.; Goldberg, Richard M.; Mayer, Robert J.; Blanke ...

Radar scours thousands of media and news sources across the internet 24/7.

Access interviews, webinars, TV appearances, blog posts, columns, whitepapers, PDFs, profressional profiles, and more.

image

Education

Institution

Degree Type

University of California, Irvine

Bachelor of Science

David Geffen School of Medicine at UCLA

Doctor of Medicine

Work History

Title

Employer

Medical Director

UNC Lineberger Comprehensive Cancer Center (Chapel Hill, NC)

Medical Director

UNC Lineberger Comprehensive Cancer Center (Chapel Hill, NC)

Joseph W. and Jackie J. Cusick Professor of Oncology

Indiana University School of Medicine (Indianapolis, IN)

What to expect from a Radar profile

Access detailed litigation history and performance metrics.

Access your Radar profile through Expert iQ, our secure, cloud-based platform that hosts AI-driven insights.

Delivered in 3–5 business days

Receive your profile swiftly, with Radar gathering intelligence from thousands of data points.

24/7 monitoring for 12 months

Stay informed with continuous monitoring and live alerts, ensuring your profile is always up-to-date.

bakground
Expert iQ logo
Expert Radar features